BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 31.01.1994

Opportunity for a License: Assay To Screen Inhibitors of HIV-1 Aspartyl Protease

The National Institutes of Health seeks to license a novel radiometric assay system for identifying new anti-retroviral drugs targeting HIV-1 aspartyl proteinase.

Source: Federal Register — Health and Human ServicesOpen original release →